ANIK up +1.76% percent Today $ANIK High is at 41.88 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
ANIK up +1.76% percent Today $ANIK High is at 41.88 and the Low 41.31 with current volume of 89,307.

Recent News posted below.

Anika Therapeutics Inc ANIK other info.
http://investorshangout.com/Anika-Therapeutic...NIK-53336/

ANIK Anika Therapeutics Inc Recent Headline News

Update: Anika Therapeutics Q3 2014 Earnings
Andy Batts - at Seeking Alpha - 26 mins ago

ANIK: 41.46 (+0.55)

Global Anti-Adhesion Products Industry
PR Newswire - Tue Nov 11, 10:23AM CST
This report analyzes the worldwide markets for Anti-Adhesion Products in US$ Thousands by the following three major Application Areas: General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Surgical Procedures. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 19 companies including many key and niche players such as -
ANIK: 41.46 (+0.55)

Center for Medicare & Medicaid Services Announces That a Unique Reimbursement Code is Assigned to Anika's MONOVISC(R) Product
Business Wire - Mon Nov 10, 3:05PM CST
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Center for Medicare & Medicaid Services ("CMS" has assigned a unique Healthcare Common Procedure Coding System ("HCPCS" code, or J-Code, to its product MONOVISC(R). The issuance of this code by CMS sets national Medicare reimbursement rates for the product. The new J-Code becomes effective on January 1, 2015.
ANIK: 41.46 (+0.55)

Anika Therapeutics' (ANIK) CEO Charles Sherwood on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sun Nov 02, 5:25AM CST

ANIK: 41.46 (+0.55)

Anika ups revenues 24% in Q3
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 6:10PM CDT

ANIK: 41.46 (+0.55)

Anika Therapeutics beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 3:11PM CDT

ANIK: 41.46 (+0.55)

Anika Therapeutics Reports Third-Quarter 2014 Financial Results
Business Wire - Wed Oct 29, 3:05PM CDT
--Earnings per Share Increase to $0.40 from $0.33
ANIK: 41.46 (+0.55)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 4:35PM CDT

CSGP: 160.02 (+0.04), CNW: 46.03 (-0.32), ACMP: 62.11 (-0.53), BGC: 13.98 (-0.07), DAC: 6.24 (-0.04), AIZ: 67.70 (-0.30), AEM: 24.26 (+1.25), ESRT: 15.95 (-0.07), CAR: 57.31 (-0.66), CWT: 25.35 (-0.28), AHL: 43.28 (-0.27), CLUB: 6.10 (-0.67), CAVM: 52.50 (-0.10), CJES: 18.83 (-0.09), FB: 74.26 (-0.74), AKAM: 60.89 (-0.18), EXR: 58.52 (-0.13), DWA: 21.91 (-0.18), EXL: 12.93 (-0.09), ANIK: 41.46 (+0.55), CLD: 13.07 (+0.04), ALL: 66.62 (-0.14), DRIV: 24.52 (-0.25), EQIX: 222.40 (+4.37), ESV: 39.45 (-0.47), ASGN: 30.00 (-0.02), AUY: 3.93 (+0.27), ACHC: 61.11 (-0.18), CALX: 11.32 (-0.06), CSII: 29.98 (-0.04), AFOP: 13.70 (unch), ARAY: 7.10 (+0.20), AEGN: 19.50 (-0.32), ATML: 7.57 (-0.03), CENX: 27.46 (+0.14), CUZ: 12.83 (-0.17), CACI: 85.30 (+1.38), ACGL: 57.19 (-0.07), AXS: 49.18 (-0.04), BMR: 21.58 (-0.07), ARII: 68.16 (-0.92), CBG: 32.47 (+0.66), CW: 70.59 (+0.03), DRE: 19.68 (+0.09), ABX: 11.79 (+0.44), CBL: 18.98 (-0.42), CHDN: 104.26 (-0.17), CMO: 12.62 (-0.04), CATM: 38.16 (+0.24), BLKB: 44.27 (-0.48), BIDU: 247.58 (unch), EQY: 24.16 (+0.01), ARRS: 28.63 (-1.83), ALDW: 18.69 (-0.55), CRUS: 19.56 (-0.13), CEMP: 14.27 (+0.47), CRL: 64.03 (+0.10)

Anika Therapeutics reports on October 29
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:57PM CDT

ANIK: 41.46 (+0.55)

Anika Therapeutics Announces Date of Third-Quarter 2014 Financial Results Conference Call
Business Wire - Thu Oct 16, 3:05PM CDT
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2014 financial results after the close of the market on Wednesday, October 29, 2014. The company plans to hold a conference call the next day, Thursday, October 30 at 9:00 a.m. ET to discuss its financial results, business highlights and outlook. In addition, the company will answer questions concerning business and financial developments and trends, and other business and financial matters affecting the company, some of the responses to which may contain information that has not been previously disclosed.
ANIK: 41.46 (+0.55)

Global Regenerative Medicine (Bone and Joint) Market Forecasts and Opportunities, 2019
M2 - Wed Oct 08, 4:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5879mp/regenerative) has announced the addition of the "Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019 U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. The global market for regenerative medicine bone and joint application is dominated by various bone graft substitute in 2012. However, it is expected that tissue engineering will become a lucrative market in future. Factors such as growing geriatric population, favorable government support and increasing bone and joint reconstructive surgeries accentuate growth of the global regenerative medicine bone and joint application market. Scope of the Report The global regenerative medicine (bone and joint) market is segmented as follows: - Regenerative Medicine (Bone and Joint) Market, by Technology - Stem Cell Therapy - Biomaterial - Tissue Engineering Regenerative Medicine (Bone and Joint) Market, by Application - Bone Graft Substitutes - Osteoarticular Diseases - Allogeneic Bones - Autogenic Bones - Others Major market players profiled in this report includes: - Anika Therapeutics, Inc - Arthrex, Inc - Baxter International, Inc. - CONMED Corporation - DePuy Synthes, Inc. - Medtronic, Inc. - Smith & Nephew PLC - Stryker Corporation - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/58...generative
ZMH: 110.95 (+0.53), SNN: 33.87 (+0.41), MDT: 68.82 (+0.11), BAX: 70.50 (-0.13), CNMD: 42.29 (+0.20), ANIK: 41.46 (+0.55), SYK: 88.53 (+0.09)

11.5% Return Seen to Date on SmarTrend Anika Therapeutics Call (ANIK)
Comtex SmarTrend(R) - Mon Sep 29, 11:21AM CDT
SmarTrend identified a Downtrend for Anika Therapeutics (NASDAQ:ANIK) on August 1st, 2014 at $40.68. In approximately 2 months, Anika Therapeutics has returned 11.53% as of today's recent price of $35.99.
ANIK: 41.46 (+0.55)

Global Anti-Adhesion Products - Strategic Business Report 2014
M2 - Mon Aug 18, 7:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9msqpk/antiadhesion) has announced the addition of the "Anti-Adhesion Products - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Anti-Adhesion Products in US$ Thousands by the following three major Application Areas: General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Surgical Procedures. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 19 companies including many key and niche players such as: - Anika Therapeutics, Inc. - Baxter Healthcare Ltd. - Covidien - Ethicon, Inc. - FzioMed, Inc. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Study Reliability and Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions and Scope of Study - Adhesion - Anti-Adhesion Products - General/Abdominal Surgery - Pelvic/Gynecological Surgery - Other Surgical Procedures II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW 2. ADVANCED WOUND CARE TECHNOLOGIES AN OVERVIEW OF THE LARGER MARKET 3. PRODUCT OVERVIEW 4. PRODUCT INNOVATIONS/APPROVALS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 19 (including Divisions/Subsidiaries 22) - The United States (9) - Japan (1) - Europe (11) - Germany (2) - The United Kingdom (3) - Rest of Europe (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/9m...tiadhesion
ANIK: 41.46 (+0.55)

Regenerative Medicine Market 2014-2020 - Global Strategic Business Report
M2 - Thu Aug 14, 2:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jwcn7x/regenerative) has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. The report profiles 46 companies including many key and niche players such as: - AlloSource - Anika Therapeutics, Inc. - Biomet, Inc. - Bioventus LLC - DePuy Synthes Companies Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Regenerative Medicine A Macro Perspective 3. Bone And Joint Regenerative Medicine An Overview 4. Competitive Landscape 5. Regenerative Medicine In Other Areas 6. Regulatory Environment 7. A Peek Into The Global Orthopedic Industry 8. Research And Development 9. Product Overview 10. Product Innovations/Introductions 11. Recent Industry Activity 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Japan 3. Europe 4. Asia-Pacific 5. Rest Of World IV. Competitive Landscape Total Companies Profiled: 46 (including Divisions/Subsidiaries 51) - The United States (38) - Europe (11) - Germany (2) - The United Kingdom (2) - Rest of Europe (7) - Asia-Pacific (Excluding Japan) (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/jw...generative
ANIK: 41.46 (+0.55)

Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis to 2019 for the $6.4 Billion Industry
M2 - Mon Aug 11, 5:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/sb3q8w/regenerative) has announced the addition of the "Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019. The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. Moreover, tissue engineering is expected to grow at the highest CAGR during the forecast period. In addition, the global market for regenerative medicine (bone and joint) is segmented based on application as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. Autogenic bone application segment is expected to grow at the highest CAGR during the forecast period 2013 to 2019. The global regenerative medicine (bone and joint) market is segmented as follows: - Regenerative Medicine (Bone and Joint) Market, by Technology - Stem Cell Therapy - Biomaterial - Tissue Engineering Regenerative Medicine (Bone and Joint) Market, by Application - Bone Graft Substitutes - Osteoarticular Diseases - Allogeneic Bones - Autogenic Bones - Others Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - Anika Therapeutics, Inc. - Arthrex, Inc. - Baxter International, Inc. - CONMED Corporation - DePuy Synthes, Inc. - Medtronic, Inc. - Smith & Nephew plc - Stryker Corporation - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/sb...generative
ZMH: 110.95 (+0.53), SNN: 33.87 (+0.41), MDT: 68.81 (+0.10), BAX: 70.49 (-0.14), CNMD: 42.29 (+0.20), ANIK: 41.46 (+0.55), SYK: 88.53 (+0.09)

Anika Therapeutics to Present at Canaccord Genuity 34th Annual Growth Conference
Business Wire - Mon Aug 04, 3:05PM CDT
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 10:30 a.m. ET. The conference is being held at the InterContinental Hotel in Boston, Massachusetts.
ANIK: 41.46 (+0.55)

Nasdaq stocks posting largest percentage decreases
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
UIHC: 19.00 (unch), BGFV: 12.97 (+0.04), WATT: 9.50 (-0.19), MGAM: 35.39 (+0.20), DEST: 14.91 (-0.37), EDGW: 7.15 (+0.13), MINI: 44.25 (+0.71), ANIK: 41.46 (+0.55), GLUU: 3.80 (+0.01), BWLD: 161.72 (+2.49), MMSI: 15.30 (+0.11), FEIC: 83.86 (-0.15)

Major Indexes Extend Losses; S&P 500 Breaks 50-Day Line
at Investor's Business Daily - Thu Jul 31, 10:50AM CDT
Stocks lost more ground near the midpoint of Thursday's session. They had been under pressure from the start amid Argentina's debt default and mixed economic data. The Nasdaq slumped 1.6%, hurt by software and chip stocks. The S&P 500 dropped 1.3%,...
KNDI: 15.61 (+0.75), KS: 31.07 (-0.41), YELP: 60.98 (+1.91), ANIK: 41.46 (+0.55)

Anika Therapeutics partners with Medline for marketing of wound care product Hyalomatrix
M2 - Thu Jul 31, 6:15AM CDT
Therapeutic products company Anika Therapeutics (NasdaqGS:ANIK) reported on Wednesday the execution of an exclusive agreement to commercialise its Hyalomatrix in the US in partnership with Medline Industries
ANIK: 41.46 (+0.55)

Anika Therapeutics Inc. (ANIK) Stock Research Links

ANIK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 191

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 118

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 276

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 235

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Charter Investigation Puts ACP Exit Claims Under Lens

Updated Category News Views 258

Charter’s ACP hangover has grown from an operating headache into a governance question. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether Charter Communications officers or directors breached fiduciary duties or otherwise broke state or federal law. That is not a finding of wrongdoing, and investors ought to keep that distinction...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 176

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 47

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Cameco Prepares for Leadership Transition at Westinghouse Electric

Updated Category News Views 149

Cameco Acknowledges Leadership Changes at Westinghouse Cameco (TSX: CCO; NYSE: CCJ) has made a significant acknowledgment regarding the leadership transition at Westinghouse Electric Company. This moment marks a pivotal change as Patrick Fragman announces his decision to step down from his role as President and CEO of Westinghouse. Effective March 31, 2025, Patrick will...

Continue Reading
Discover Innovations at Taiwan Innotech Expo 2025 in AI

Updated Category News Views 296

Taiwan Innotech Expo 2025 Highlights The Taiwan Innotech Expo (TIE) is set to showcase the critical role of artificial intelligence (AI) in transforming various industries. Hosted in Taipei, this annual event brings together influential government agencies, including the Ministry of Economic Affairs and the National Science and Technology Council. The expo will open its...

Continue Reading
Explore Antarctica: A Unique Journey with Atlas Ocean Voyages

Updated Category News Views 225

Unveiling a Unique Antarctic Adventure Atlas Ocean Voyages, known for its intimate luxury expeditions, is set to elevate its offerings with a remarkable new program on board the luxury ship, World Traveller. This journey promises to provide guests not only breathtaking landscapes but also enriching experiences through collaboration with renowned photographer Karim Iliya...

Continue Reading
atNorth's Bold Expansion: Norway Meets Mega Data Site

Updated Category News Views 48

Setting the Stage in Haugaland Here's a bold move from atNorth that's got folks talking. This Nordic heavyweight isn't just dancing around the edges; they're making a big splash by staking their claim in Norway with a mega site that’s got ‘future’ written all over it. We’re talking a data center in Haugaland, starting with 120MW and aiming for a solid 350MW once...

Continue Reading
Volvo Group's CES Keynote: Paving the Path to Sustainability

Updated Category News Views 192

Volvo Group Spearheads Sustainability at CES At CES, the Consumer Electronics Show, Volvo Group’s President and CEO, Martin Lundstedt, captured the audience with a strong call to action regarding the future of transportation and infrastructure. Lundstedt emphasized the dire need for urgent changes in the industry to combat climate change, setting the tone for a vibrant...

Continue Reading